期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
氯氮平在美国的应用现状(英文) 被引量:1
1
作者 Deanna L.KELLY Heidi J.WEHRING Gopal VYAS 《上海精神医学》 2012年第2期110-113,共4页
Clozapine is the only antipsychotic in the United States that has been approved by the Food and Drug Administration (FDA) for treatment-resistant schizophrenia. It provides effective treatment even when patients do no... Clozapine is the only antipsychotic in the United States that has been approved by the Food and Drug Administration (FDA) for treatment-resistant schizophrenia. It provides effective treatment even when patients do not respond to other second- generation antipsychotics.[1] It also remains the most effective antipsychotic available. No existing first or second-generation antipsychotic has been 展开更多
关键词 氯氮平 美国 精神分裂症 精神病 药物 FDA 管理局 第二代
下载PDF
轻微精神病综合征:明确识别的好处(英文)
2
作者 Jason SCHIFFMAN William T.CARPENTER 《上海精神医学》 CSCD 2015年第1期48-51,共4页
符合轻微精神病综合征(attenuated psychosis syndrome,APS)标准的个体具有独有的特征,越来越多的文献认为对符合APS标准的个体提供服务在临床上能获益,因而APS的诊断在精神病学中有着重要作用,但过去却被忽视了。推行这一诊断将有助于... 符合轻微精神病综合征(attenuated psychosis syndrome,APS)标准的个体具有独有的特征,越来越多的文献认为对符合APS标准的个体提供服务在临床上能获益,因而APS的诊断在精神病学中有着重要作用,但过去却被忽视了。推行这一诊断将有助于减少对具有前驱期精神病性状态个体的过度诊断和治疗。因为青少年是被诊断为APS的主要群体,所以也应鼓励那些主要为青少年服务的医生接受关于轻微精神病综合征的全面培训。虽然只有一部分APS个体最终会发展为精神病,但是临床上所有的APS个体都需要得到帮助——无论他们的转归如何。DSM-5正式列出APS,这将有利于开展如何识别这类个体的临床需求以及如何满足这些需求的研究。 展开更多
关键词 精神病 综合征 减毒 利益 临床医生 APS 诊断 服务
下载PDF
High-Performance Magnetic-core Coils for Targeted Rodent Brain Stimulations
3
作者 Hedyeh Bagherzadeh Qinglei Meng +3 位作者 Hanbing Lu Elliott Hong Yihong Yang Fow-Sen Choa 《Biomedical Engineering Frontiers》 2022年第1期82-92,共11页
Objective and Impact Statement.There is a need to develop rodent coils capable of targeted brain stimulation for treating neuropsychiatric disorders and understanding brain mechanisms.We describe a novel rodent coil d... Objective and Impact Statement.There is a need to develop rodent coils capable of targeted brain stimulation for treating neuropsychiatric disorders and understanding brain mechanisms.We describe a novel rodent coil design to improve the focality for targeted stimulations in small rodent brains.Introduction.Transcranial magnetic stimulation(TMS)is becoming increasingly important for treating neuropsychiatric disorders and understanding brain mechanisms.Preclinical studies permit invasive manipulations and are essential for the mechanistic understanding of TMS effects and explorations of therapeutic outcomes in disease models.However,existing TMS tools lack focality for targeted stimulations.Notably,there has been limited fundamental research on developing coils capable of focal stimulation at deep brain regions on small animals like rodents.Methods.In this study,ferromagnetic cores are added to a novel angle-tuned coil design to enhance the coil performance regarding penetration depth and focality.Numerical simulations and experimental electric field measurements were conducted to optimize the coil design.Results.The proposed coil system demonstrated a significantly smaller stimulation spot size and enhanced electric field decay rate in comparison to existing coils.Adding the ferromagnetic core reduces the energy requirements up to 60%for rodent brain stimulation.The simulated results are validated with experimental measurements and demonstration of suprathreshold rodent limb excitation through targeted motor cortex activation.Conclusion.The newly developed coils are suitable tools for focal stimulations of the rodent brain due to their smaller stimulation spot size and improved electric field decay rate. 展开更多
关键词 STIMULATION MANIPULATION BECOMING
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部